ATE223406T1 - 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression - Google Patents
1,4-disubstitutierte cyclohexanderivate zur behandlung von depressionInfo
- Publication number
- ATE223406T1 ATE223406T1 AT00903156T AT00903156T ATE223406T1 AT E223406 T1 ATE223406 T1 AT E223406T1 AT 00903156 T AT00903156 T AT 00903156T AT 00903156 T AT00903156 T AT 00903156T AT E223406 T1 ATE223406 T1 AT E223406T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen
- treatment
- depression
- halogen
- alkyl
- Prior art date
Links
- -1 1,4-DISUBSTITUTED CYCLOHEXANE Chemical class 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 235000013877 carbamide Nutrition 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 229910052757 nitrogen Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22655299A | 1999-01-07 | 1999-01-07 | |
| PCT/US2000/000348 WO2000040579A1 (en) | 1999-01-07 | 2000-01-06 | New 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223406T1 true ATE223406T1 (de) | 2002-09-15 |
Family
ID=22849378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00903156T ATE223406T1 (de) | 1999-01-07 | 2000-01-06 | 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1140919B1 (de) |
| JP (1) | JP2002534426A (de) |
| CN (1) | CN1335844A (de) |
| AT (1) | ATE223406T1 (de) |
| AU (1) | AU2494400A (de) |
| CA (1) | CA2355361A1 (de) |
| DE (1) | DE60000405T2 (de) |
| DK (1) | DK1140919T3 (de) |
| ES (1) | ES2182775T3 (de) |
| PT (1) | PT1140919E (de) |
| WO (1) | WO2000040579A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004531506A (ja) | 2001-03-29 | 2004-10-14 | ブリストル−マイヤーズ スクイブ カンパニー | 選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体 |
| CN100391974C (zh) * | 2006-01-09 | 2008-06-04 | 浙江理工大学 | 一种重组胶原蛋白及其合成和表达纯化方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3907974A1 (de) * | 1989-03-11 | 1990-09-13 | Merck Patent Gmbh | Indolderivate |
| US4975445A (en) * | 1989-12-06 | 1990-12-04 | Warner-Lambert Company | Substituted cyclohexenes as central nervous system agents |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| US5322851A (en) * | 1990-07-02 | 1994-06-21 | H. Lundbeck A/S | Indole derivatives |
| US5124332A (en) * | 1991-01-28 | 1992-06-23 | Warner-Lambert Company | Substituted indoles as central nervous system agents |
| US5314896A (en) * | 1991-11-20 | 1994-05-24 | Warner-Lambert Company | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| GB9300194D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
| CN1184425A (zh) * | 1995-03-20 | 1998-06-10 | 伊莱利利公司 | 5-取代-3-(1,2,3,6-四氢吡啶-4-基)-和3-(哌啶-4-基)-1h-吲哚:新型5-ht1f激动剂 |
| TW530054B (en) * | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
-
2000
- 2000-01-06 ES ES00903156T patent/ES2182775T3/es not_active Expired - Lifetime
- 2000-01-06 JP JP2000592287A patent/JP2002534426A/ja active Pending
- 2000-01-06 CA CA002355361A patent/CA2355361A1/en not_active Abandoned
- 2000-01-06 AU AU24944/00A patent/AU2494400A/en not_active Abandoned
- 2000-01-06 CN CN00802511A patent/CN1335844A/zh active Pending
- 2000-01-06 DE DE60000405T patent/DE60000405T2/de not_active Expired - Fee Related
- 2000-01-06 PT PT00903156T patent/PT1140919E/pt unknown
- 2000-01-06 DK DK00903156T patent/DK1140919T3/da active
- 2000-01-06 AT AT00903156T patent/ATE223406T1/de not_active IP Right Cessation
- 2000-01-06 WO PCT/US2000/000348 patent/WO2000040579A1/en not_active Ceased
- 2000-01-06 EP EP00903156A patent/EP1140919B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1335844A (zh) | 2002-02-13 |
| ES2182775T3 (es) | 2003-03-16 |
| AU2494400A (en) | 2000-07-24 |
| DE60000405D1 (de) | 2002-10-10 |
| DK1140919T3 (da) | 2002-12-30 |
| CA2355361A1 (en) | 2000-07-13 |
| EP1140919B1 (de) | 2002-09-04 |
| DE60000405T2 (de) | 2003-08-07 |
| EP1140919A1 (de) | 2001-10-10 |
| WO2000040579A1 (en) | 2000-07-13 |
| JP2002534426A (ja) | 2002-10-15 |
| PT1140919E (pt) | 2002-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1260512T3 (da) | Hidtil ukendte, cykliske amidderivater | |
| AP2003002841A0 (en) | Quinazolines as MMP-13 inhibitors | |
| DK1277736T3 (da) | Hidtil ukendte bicykliske forbindelser | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| UA83243C2 (ru) | Соединения, которые ингибируют натриезависимый переносчик глюкозы | |
| GB9801690D0 (en) | Therapeutic agents | |
| AU2003254852A8 (en) | Fused heterocyclic compounds as peptidase inhibitors | |
| AP1816A (en) | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists. | |
| ATE224872T1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
| TR199900096T2 (xx) | Bradykinin B2 antagonistleri olarak elveri�li N-benzensulfonil-L-prolin t�revleri. | |
| ATE239741T1 (de) | Derivate der phosphonsäure zur inhibierung von carboxypeptidase b | |
| NO995289D0 (no) | Benzimidazol-derivater | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| ATE283840T1 (de) | Chondrogonese promotoren und indolin-2-on derivate | |
| ATE223406T1 (de) | 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression | |
| DE69902766D1 (de) | N-aryloxyethylaminderivate zur behandlung der depression | |
| SE9704770D0 (sv) | New use | |
| ATE250027T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| ES2193047T3 (es) | (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas. | |
| DE69916577D1 (de) | Azetidincarboxamid-derivate zur behandlung von zns störungen | |
| DE69816832D1 (de) | Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| ATE220665T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| ATE227718T1 (de) | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |